These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6855860)
21. The influence of age and of the inducer phenobarbital on the cytochrome P-450 dependent monooxygenation of drugs in rat liver. Müller D; Klinger W Pharmazie; 1978 Jul; 33(7):397-400. PubMed ID: 103104 [No Abstract] [Full Text] [Related]
22. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Neveu MJ; Babcock KL; Hertzberg EL; Paul DL; Nicholson BJ; Pitot HC Cancer Res; 1994 Jun; 54(12):3145-52. PubMed ID: 8205533 [TBL] [Abstract][Full Text] [Related]
23. [Description of cytochrome p-450 research]. Wang XL Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):233-7. PubMed ID: 6359412 [No Abstract] [Full Text] [Related]
24. Induction of aryl hydrocarbon hydroxylase and carbon monoxide-binding hemoproteins in mouse epidermis by tobacco carcinogens. Norred WP; Akin FJ Biochem Pharmacol; 1976 Mar; 25(6):732-4. PubMed ID: 179556 [No Abstract] [Full Text] [Related]
25. Is a photo-oxidation product of histidine one of the triggers of induction of cytochrome P-450 drug-metabolizing enzyme systems? Dayton PG; Israili ZH Drug Metab Dispos; 1981; 9(4):391. PubMed ID: 6114841 [No Abstract] [Full Text] [Related]
26. Enzyme induction (second of three parts). Gelehrter TD N Engl J Med; 1976 Mar; 294(11):589-95. PubMed ID: 54876 [No Abstract] [Full Text] [Related]
27. 2,3,7,8-Tetrachlorodibenzofuran in a commercially available 99% pure polychlorinated biphenyl isomer identified as the inducer of hepatic cytochrome P-448 and aryl hydrocarbon hydroxylase in the rat. Goldstein JA; Hass JR; Linko P; Harvan DJ Drug Metab Dispos; 1978; 6(3):258-64. PubMed ID: 26546 [No Abstract] [Full Text] [Related]
28. Drug metabolism in adult rat hepatocytes in primary monolayer culture. Guzelian PS; Bissell DM; Meyer UA Gastroenterology; 1977 Jun; 72(6):1232-9. PubMed ID: 404208 [TBL] [Abstract][Full Text] [Related]
29. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium. Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530 [TBL] [Abstract][Full Text] [Related]
30. Effects of dietary constituents on the metabolism of chemical carcinogens. Wattenberg LW Cancer Res; 1975 Nov; 35(11 Pt. 2):3326-31. PubMed ID: 1104144 [TBL] [Abstract][Full Text] [Related]
31. Selections for and against cells possessing cytochrome P450IA1-dependent aryl hydrocarbon hydroxylase activity. Hankinson O Methods Enzymol; 1991; 206():381-400. PubMed ID: 1784225 [No Abstract] [Full Text] [Related]
32. The 1990 Pharmaceutical Manufacturers Association of Canada keynote lecture. The role of the cytochromes P450 in the detoxication and activation of drugs and other chemicals. Parke DV; Ioannides C; Lewis DF Can J Physiol Pharmacol; 1991 May; 69(5):537-49. PubMed ID: 1863904 [TBL] [Abstract][Full Text] [Related]
33. Metabolic activation of carcinogens by keratinocytes. Bickers DR Ann N Y Acad Sci; 1988; 548():102-7. PubMed ID: 2470286 [No Abstract] [Full Text] [Related]
34. Human CYPs: in vivo and clinical aspects. Pelkonen O Drug Metab Rev; 2002; 34(1-2):37-46. PubMed ID: 11996010 [No Abstract] [Full Text] [Related]
36. Cytochrome P-450: a pharmacological necessity or a biochemical curiosity? Burke MD Biochem Pharmacol; 1981 Feb; 30(3):181-7. PubMed ID: 7013767 [No Abstract] [Full Text] [Related]
37. Monoclonal antibodies for studies on xenobiotic and endobiotic metabolism. Cytochromes P-450 as paradigm. Gelboin HV; Friedman FK Biochem Pharmacol; 1985 Jul; 34(13):2225-34. PubMed ID: 3893437 [No Abstract] [Full Text] [Related]
38. Cytochrome P-450-dependent drug metabolism in skin. Ahmad N; Agarwal R; Mukhtar H Clin Dermatol; 1996; 14(4):407-15. PubMed ID: 8862917 [No Abstract] [Full Text] [Related]
39. Cytochrome P-450 and drug development for skin diseases. Ahmad N; Agarwal R; Mukhtar H Skin Pharmacol; 1996; 9(4):231-41. PubMed ID: 8896114 [TBL] [Abstract][Full Text] [Related]
40. Advances in genetics and immunology: the importance of basic research to prevention of occupational diseases. Omenn GS Arch Environ Health; 1984; 39(3):173-82. PubMed ID: 6380422 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]